{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:05:43Z","timestamp":1794405943340,"version":"4.9.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-22376-1","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T14:14:14Z","timestamp":1743516854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Trends and projections of Non-Hodgkin lymphoma burden (1990\u20132040): a global burden of disease 2021 analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Shengqiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"issue":"1","key":"22376_CR1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"22376_CR2","first-page":"176","volume":"26","author":"L de Leval","year":"2020","unstructured":"de Leval L, Jaffe ES. Lymphoma Classif Cancer J. 2020;26(3):176\u201385.","journal-title":"Lymphoma Classif Cancer J"},{"issue":"10091","key":"22376_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","volume":"390","author":"JO Armitage","year":"2017","unstructured":"Armitage JO, Gascoyne RD, Lunning MA, Cavalli F. Non-Hodgkin lymphoma. Lancet. 2017;390(10091):298\u2013310.","journal-title":"Lancet"},{"issue":"3","key":"22376_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"22376_CR5","doi-asserted-by":"crossref","unstructured":"Thandra KC, Barsouk A, Saginala K, Padala SA, Barsouk A, Rawla P. Epidemiology of Non-Hodgkin\u2019s Lymphoma. Med Sci (Basel), 2021, 9(1).","DOI":"10.3390\/medsci9010005"},{"issue":"1","key":"22376_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/ajh.26744","volume":"98","author":"C Radkiewicz","year":"2023","unstructured":"Radkiewicz C, Bruchfeld JB, Weibull CE, Jeppesen ML, Frederiksen H, Lambe M, Jakobsen L, El-Galaly TC, Smedby KE, W\u00e4sterlid T. Sex differences in lymphoma incidence and mortality by subtype: A population-based study. Am J Hematol. 2023;98(1):23\u201330.","journal-title":"Am J Hematol"},{"key":"22376_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.puhe.2023.11.023","volume":"226","author":"Z Shen","year":"2024","unstructured":"Shen Z, Tan Z, Ge L, Wang Y, Xing X, Sang W, Cai G. The global burden of lymphoma: estimates from the global burden of disease 2019 study. Public Health. 2024;226:199\u2013206.","journal-title":"Public Health"},{"issue":"10125","key":"22376_CR8","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nik\u0161i\u0107 M, Bonaventure A, Valkov M, Johnson CJ, Est\u00e8ve J, Ogunbiyi OJ, Azevedo ESG, Chen WQ, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023\u201375.","journal-title":"Lancet"},{"key":"22376_CR9","doi-asserted-by":"publisher","first-page":"738693","DOI":"10.3389\/fmed.2021.738693","volume":"8","author":"W Cai","year":"2021","unstructured":"Cai W, Zeng Q, Zhang X, Ruan W. Trends analysis of Non-Hodgkin lymphoma at the National, regional, and global level, 1990\u20132019: results from the global burden of disease study 2019. Front Med (Lausanne). 2021;8:738693.","journal-title":"Front Med (Lausanne)"},{"key":"22376_CR10","doi-asserted-by":"publisher","first-page":"1059914","DOI":"10.3389\/fonc.2023.1059914","volume":"13","author":"Y Chu","year":"2023","unstructured":"Chu Y, Liu Y, Fang X, Jiang Y, Ding M, Ge X, Yuan D, Lu K, Li P, Li Y, Xu H, Fan J, Zhou X, Wang X. The epidemiological patterns of non-Hodgkin lymphoma: global estimates of disease burden, risk factors, and Temporal trends. Front Oncol. 2023;13:1059914.","journal-title":"Front Oncol"},{"issue":"3","key":"22376_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335\u201351.","journal-title":"Stat Med"},{"issue":"29","key":"22376_CR12","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/sim.3733","volume":"28","author":"LX Clegg","year":"2009","unstructured":"Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med. 2009;28(29):3670\u201382.","journal-title":"Stat Med"},{"issue":"3","key":"22376_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/bimj.201500263","volume":"59","author":"A Riebler","year":"2017","unstructured":"Riebler A, Held L. Projecting the future burden of cancer: bayesian age-period-cohort analysis with integrated nested Laplace approximations. Biom J. 2017;59(3):531\u201349.","journal-title":"Biom J"},{"issue":"10440","key":"22376_CR14","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","volume":"403","author":"Burden of disease scenarios","year":"2024","unstructured":"Burden of disease scenarios. For 204 countries and territories, 2022\u20132050: a forecasting analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2204\u201356.","journal-title":"Lancet"},{"issue":"10440","key":"22376_CR15","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"Global incidence","year":"2024","unstructured":"Global incidence. prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2133\u201361.","journal-title":"Lancet"},{"key":"22376_CR16","doi-asserted-by":"crossref","unstructured":"Huang J, Chan SC, Lok V, Zhang L, Lucero-Prisno DE 3rd, Xu W, Zheng ZJ, Elcarte E, Withers M, Wong MCS. Global burden, risk factors, and trends of non-Hodgkin lymphoma: A worldwide analysis of cancer registries. Cancer Med. 2024;13(5):e7056.","DOI":"10.1002\/cam4.7056"},{"issue":"1","key":"22376_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1053\/j.seminhematol.2018.05.007","volume":"56","author":"ES Jaffe","year":"2019","unstructured":"Jaffe ES. Diagnosis and classification of lymphoma: impact of technical advances. Semin Hematol. 2019;56(1):30\u20136.","journal-title":"Semin Hematol"},{"issue":"5","key":"22376_CR18","first-page":"312","volume":"36","author":"P Tamayo","year":"2017","unstructured":"Tamayo P, Mart\u00edn A, D\u00edaz L, Cabrero M, Garc\u00eda R, Garc\u00eda-Talavera P, Caballero D. (18)F-FDG PET\/CT in the clinical management of patients with lymphoma. Rev Esp Med Nucl Imagen Mol. 2017;36(5):312\u201321.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"Suppl 1","key":"22376_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000447577","volume":"91","author":"R Nair","year":"2016","unstructured":"Nair R, Arora N, Mallath MK. Epidemiology of Non-Hodgkin\u2019s lymphoma in India. Oncology. 2016;91(Suppl 1):18\u201325.","journal-title":"Oncology"},{"key":"22376_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.leukres.2018.03.014","volume":"69","author":"JL Etter","year":"2018","unstructured":"Etter JL, Cannioto R, Soh KT, Alquassim E, Almohanna H, Dunbar Z, Joseph JM, Balderman S, Hernandez-Ilizaliturri F, Moysich KB. Lifetime physical inactivity is associated with increased risk for hodgkin and non-Hodgkin lymphoma: A case-control study. Leuk Res. 2018;69:7\u201311.","journal-title":"Leuk Res"},{"issue":"2","key":"22376_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.clml.2013.10.005","volume":"14","author":"JJ Castillo","year":"2014","unstructured":"Castillo JJ, Ingham RR, Reagan JL, Furman M, Dalia S, Mitri J. Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies. Clin Lymphoma Myeloma Leuk. 2014;14(2):122\u201330.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"7","key":"22376_CR22","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1002\/ijc.22762","volume":"121","author":"SC Larsson","year":"2007","unstructured":"Larsson SC, Wolk A. Obesity and risk of non-Hodgkin\u2019s lymphoma: a meta-analysis. Int J Cancer. 2007;121(7):1564\u201370.","journal-title":"Int J Cancer"},{"issue":"12","key":"22376_CR23","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1002\/cncr.25114","volume":"116","author":"SM Geyer","year":"2010","unstructured":"Geyer SM, Morton LM, Habermann TM, Allmer C, Davis S, Cozen W, Severson RK, Lynch CF, Wang SS, Maurer MJ, Hartge P, Cerhan JR. Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study. Cancer. 2010;116(12):2993\u20133000.","journal-title":"Cancer"},{"issue":"8","key":"22376_CR24","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3109\/10428194.2012.753543","volume":"54","author":"CJ Kim","year":"2013","unstructured":"Kim CJ, Freedman DM, Curtis RE, Berrington de Gonzalez A, Morton LM. Risk of non-Hodgkin lymphoma after radiotherapy for solid cancers. Leuk Lymphoma. 2013;54(8):1691\u20137.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"22376_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/geronb\/gbab055","volume":"77","author":"WJ Yeung","year":"2022","unstructured":"Yeung WJ, Lee Y. Aging in East Asia: new findings on retirement, health, and Well-Being. J Gerontol B Psychol Sci Soc Sci. 2022;77(3):589\u201391.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"issue":"1","key":"22376_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1053\/j.seminoncol.2015.09.011","volume":"43","author":"PH Goncalves","year":"2016","unstructured":"Goncalves PH, Montezuma-Rusca JM, Yarchoan R, Uldrick TS. Cancer prevention in HIV-infected populations. Semin Oncol. 2016;43(1):173\u201388.","journal-title":"Semin Oncol"},{"key":"22376_CR27","doi-asserted-by":"publisher","first-page":"102370","DOI":"10.1016\/j.eclinm.2023.102370","volume":"67","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhao J, Sun P, Cheng M, Xiong Y, Sun Z, Zhang Y, Li K, Ye Y, Shuai P, Huang H, Li X, Liu Y, Wan Z. Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling study. EClinicalMedicine. 2024;67:102370.","journal-title":"EClinicalMedicine"},{"issue":"8","key":"22376_CR28","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3851\/IMP1462","volume":"14","author":"J Bohlius","year":"2009","unstructured":"Bohlius J, Schmidlin K, Costagliola D, F\u00e4tkenheuer G, May M, Caro-Murillo AM, Mocroft A, Bonnet F, Clifford G, Karafoulidou A, Miro JM, Lundgren J, Chene G, Egger M. Incidence and risk factors of HIV-related non-Hodgkin\u2019s lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antivir Ther. 2009;14(8):1065\u201374.","journal-title":"Antivir Ther"},{"issue":"1","key":"22376_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-022-00404-3","volume":"8","author":"C L\u00f3pez","year":"2022","unstructured":"L\u00f3pez C, Burkhardt B, Chan JKC, Leoncini L, Mbulaiteye SM, Ogwang MD, Orem J, Rochford R, Roschewski M, Siebert R. Burkitt lymphoma. Nat Rev Dis Primers. 2022;8(1):78.","journal-title":"Nat Rev Dis Primers"},{"issue":"993","key":"22376_CR30","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/jcp.2007.047977","volume":"84","author":"G Brady","year":"2008","unstructured":"Brady G, Macarthur GJ, Farrell PJ. Epstein-Barr virus and Burkitt lymphoma. Postgrad Med J. 2008;84(993):372\u20137.","journal-title":"Postgrad Med J"},{"issue":"4","key":"22376_CR31","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/annonc\/mdz045","volume":"30","author":"L Abar","year":"2019","unstructured":"Abar L, Sobiecki JG, Cariolou M, Nanu N, Vieira AR, Stevens C, Aune D, Greenwood DC, Chan DSM, Norat T. Body size and obesity during adulthood, and risk of lympho-haematopoietic cancers: an update of the WCRF-AICR systematic review of published prospective studies. Ann Oncol. 2019;30(4):528\u201341.","journal-title":"Ann Oncol"},{"issue":"6","key":"22376_CR32","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/bjh.18150","volume":"197","author":"LR Teras","year":"2022","unstructured":"Teras LR, Bertrand KA, Deubler EL, Chao CR, Lacey JV Jr., Patel AV, Rosner BA, Shu YH, Wang K, Zhong C, Wang SS, Birmann BM. Body size and risk of non-Hodgkin lymphoma by subtype: A pooled analysis from six prospective cohorts in the united States. Br J Haematol. 2022;197(6):714\u201327.","journal-title":"Br J Haematol"},{"key":"22376_CR33","doi-asserted-by":"publisher","first-page":"k3204","DOI":"10.1136\/bmj.k3204","volume":"362","author":"A Bowzyk Al-Naeeb","year":"2018","unstructured":"Bowzyk Al-Naeeb A, Ajithkumar T, Behan S, Hodson DJ. Non-Hodgkin lymphoma. BMJ. 2018;362:k3204.","journal-title":"BMJ"},{"issue":"4","key":"22376_CR34","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jncc.2022.08.003","volume":"2","author":"J Luo","year":"2022","unstructured":"Luo J, Craver A, Bahl K, Stepniak L, Moore K, King J, Zhang Y, Aschebrook-Kilfoy B. Etiology of non-Hodgkin lymphoma: A review from epidemiologic studies. J Natl Cancer Cent. 2022;2(4):226\u201334.","journal-title":"J Natl Cancer Cent"},{"issue":"12","key":"22376_CR35","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/oemed-2022-108371","volume":"79","author":"AJ De Roos","year":"2022","unstructured":"De Roos AJ, Fritschi L, Ward MH, Monnereau A, Hofmann J, Bernstein L, Bhatti P, Benavente Moreno Y, Benke G, Casabonne D, Clavel J, Cocco P, Huynh T, t Mannetje A, Miligi L, Piro S, Rothman N, Schinasi LH, Vajdic CM, Wang SS, Zhang Y, Slager SL, Cerhan JR. Herbicide use in farming and other jobs in relation to non-Hodgkin\u2019s lymphoma (NHL) risk. Occup Environ Med. 2022;79(12):795\u2013806.","journal-title":"Occup Environ Med"},{"issue":"5","key":"22376_CR36","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/ije\/dyz017","volume":"48","author":"ME Leon","year":"2019","unstructured":"Leon ME, Schinasi LH, Lebailly P, Beane Freeman LE, Nordby KC, Ferro G, Monnereau A, Brouwer M, Tual S, Baldi I, Kjaerheim K, Hofmann JN, Kristensen P, Koutros S, Straif K, Kromhout H, Sch\u00fcz J. Pesticide use and risk of non-Hodgkin lymphoid malignancies in agricultural cohorts from France, Norway and the USA: a pooled analysis from the AGRICOH consortium. Int J Epidemiol. 2019;48(5):1519\u201335.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"22376_CR37","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3961\/jpmph.19.100","volume":"53","author":"A Ataey","year":"2020","unstructured":"Ataey A, Jafarvand E, Adham D, Moradi-Asl E. The relationship between obesity, overweight, and the human development index in world health organization Eastern mediterranean region countries. J Prev Med Public Health. 2020;53(2):98\u2013105.","journal-title":"J Prev Med Public Health"},{"issue":"11","key":"22376_CR38","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s00247-019-04529-8","volume":"49","author":"KM McCarten","year":"2019","unstructured":"McCarten KM, Nadel HR, Shulkin BL, Cho SY. Imaging for diagnosis, staging and response assessment of hodgkin lymphoma and non-Hodgkin lymphoma. Pediatr Radiol. 2019;49(11):1545\u201364.","journal-title":"Pediatr Radiol"},{"key":"22376_CR39","doi-asserted-by":"publisher","first-page":"n166","DOI":"10.1136\/bmj.n166","volume":"372","author":"IA Agyepong","year":"2021","unstructured":"Agyepong IA, Godt S, Sombie I, Binka C, Okine V, Ingabire MG. Strengthening capacities and resource allocation for co-production of health research in low and middle income countries. BMJ. 2021;372:n166.","journal-title":"BMJ"},{"key":"22376_CR40","first-page":"1","volume":"4","author":"MG Milligan","year":"2018","unstructured":"Milligan MG, Bigger E, Abramson JS, Sohani AR, Zola M, Kayembe MKA, Medhin H, Suneja G, Lockman S, Chabner BA, Dryden-Peterson SL. Impact of HIV infection on the clinical presentation and survival of Non-Hodgkin lymphoma: A prospective observational study from Botswana. J Glob Oncol. 2018;4:1\u201311.","journal-title":"J Glob Oncol"},{"issue":"5","key":"22376_CR41","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/annonc\/mdv036","volume":"26","author":"SK Barta","year":"2015","unstructured":"Barta SK, Samuel MS, Xue X, Wang D, Lee JY, Mounier N, Ribera JM, Spina M, Tirelli U, Weiss R, Galicier L, Boue F, Little RF, Dunleavy K, Wilson WH, Wyen C, Remick SC, Kaplan LD, Ratner L, Noy A, Sparano JA. Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma. Ann Oncol. 2015;26(5):958\u201366.","journal-title":"Ann Oncol"},{"key":"22376_CR42","doi-asserted-by":"crossref","unstructured":"Tan MP. Healthcare for older people in lower and middle income countries. Age Ageing, 2022, 51(4).","DOI":"10.1093\/ageing\/afac016"},{"issue":"6","key":"22376_CR43","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/bjh.15785","volume":"185","author":"G Chantada","year":"2019","unstructured":"Chantada G, Lam CG, Howard SC. Optimizing outcomes for children with non-Hodgkin lymphoma in low- and middle-income countries by early correct diagnosis, reducing toxic death and preventing abandonment. Br J Haematol. 2019;185(6):1125\u201335.","journal-title":"Br J Haematol"},{"issue":"3","key":"22376_CR44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.explore.2020.10.004","volume":"17","author":"S Lee","year":"2021","unstructured":"Lee S, Jeon H, Park S, Lee S, Chang HJ, Eo W. A potential treatment option for elderly non-Hodgkin lymphoma patients with multiple comorbidities: two case reports and literature review. Explore (NY). 2021;17(3):265\u20139.","journal-title":"Explore (NY)"},{"issue":"3","key":"22376_CR45","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s11899-016-0319-0","volume":"11","author":"VR Bhatt","year":"2016","unstructured":"Bhatt VR. Allogeneic stem cell transplantation for Non-Hodgkin lymphoma. Curr Hematol Malig Rep. 2016;11(3):196\u2013207.","journal-title":"Curr Hematol Malig Rep"},{"issue":"1","key":"22376_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1182\/asheducation-2018.1.75","volume":"2018","author":"JB Cohen","year":"2018","unstructured":"Cohen JB. Novel therapies for relapsed\/refractory aggressive lymphomas. Hematol Am Soc Hematol Educ Program. 2018;2018(1):75\u201382.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1","key":"22376_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3324\/haematol.2016.150656","volume":"102","author":"I Hude","year":"2017","unstructured":"Hude I, Sasse S, Engert A, Br\u00f6ckelmann PJ. The emerging role of immune checkpoint Inhibition in malignant lymphoma. Haematologica. 2017;102(1):30\u201342.","journal-title":"Haematologica"},{"issue":"12","key":"22376_CR48","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/ajh.26719","volume":"97","author":"MS Alabdaljabar","year":"2022","unstructured":"Alabdaljabar MS, Durani U, Thompson CA, Constine LS, Hashmi SK. The forgotten survivor: A comprehensive review on Non-Hodgkin lymphoma survivorship. Am J Hematol. 2022;97(12):1627\u201337.","journal-title":"Am J Hematol"},{"issue":"3","key":"22376_CR49","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/ejh.14013","volume":"111","author":"Y Qin","year":"2023","unstructured":"Qin Y, He X, Chen X, Xie Z, Yang J, Yang S, Liu P, Zhou S, Zhang C, Gui L, Shi Y. Efficacy and safety of PD-1 monoclonal antibody plus rituximab in relapsed\/refractory diffuse large B cell lymphoma patients. Eur J Haematol. 2023;111(3):356\u201364.","journal-title":"Eur J Haematol"},{"issue":"2","key":"22376_CR50","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1148\/radiol.2018181519","volume":"290","author":"U Metser","year":"2019","unstructured":"Metser U, Prica A, Hodgson DC, Mozuraitis M, Eberg M, Mak V, Green B, Singnurkar A, Dudebout J, MacCrostie P, Tau N, Mittmann N, Langer DL. Effect of PET\/CT on the management and outcomes of participants with hodgkin and aggressive Non-Hodgkin lymphoma: A multicenter registry. Radiology. 2019;290(2):488\u201395.","journal-title":"Radiology"},{"key":"22376_CR51","doi-asserted-by":"publisher","first-page":"1008695","DOI":"10.3389\/fimmu.2022.1008695","volume":"13","author":"Q Pu","year":"2022","unstructured":"Pu Q, Qiao J, Liu Y, Cao X, Tan R, Yan D, Wang X, Li J, Yue B. Differential diagnosis and identification of prognostic markers for peripheral T-cell lymphoma subtypes based on flow cytometry immunophenotype profiles. Front Immunol. 2022;13:1008695.","journal-title":"Front Immunol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22376-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-22376-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22376-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T14:14:30Z","timestamp":1743516870000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-22376-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22376"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-22376-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All anonymized data were accessed and downloaded via the Global Health Data Exchange (GHDx) platform (\n                      \n                      ). Ethical approval and informed consent were not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1223"}}